Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, announced today that it will hold a conference call and live audio webcast on May 6, 2014 at 9:00 a.m. ET to discuss financial results for the quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
